Home / News / India News / Article / Union Budget 2026: Rs 10,000 crore allocated to make India biopharma hub

Union Budget 2026: Rs 10,000 crore allocated to make India biopharma hub

Presenting the Budget in Parliament, Sitharaman said the initiative is aimed at creating a robust ecosystem for biopharma and biosimilars, strengthening domestic capabilities and boosting India’s global competitiveness in high-value pharmaceutical manufacturing

Listen to this article :
Nirmala Sitharaman. Pic/PTI

Nirmala Sitharaman. Pic/PTI

Finance Minister Nirmala Sitharaman on Sunday announced a major push to position India as a global biopharmaceutical hub, unveiling a Rs 10,000-crore outlay over five years under a new Bio Pharma Shakti programme in the Union Budget 2026.

Focus on biopharma, biosimilars and high-value manufacturing

Presenting the Budget in Parliament, Sitharaman said the initiative is aimed at creating a robust ecosystem for biopharma and biosimilars, strengthening domestic capabilities and boosting India’s global competitiveness in high-value pharmaceutical manufacturing. The programme is expected to support research, innovation, manufacturing scale-up and supply-chain development across the biopharma sector.

Trending Stories

Latest Photoscta-pos

Latest VideosView All

Latest Web StoriesView All

Mid-Day FastView All

Advertisement